ACUITY STRATEGIC PARTNERS LLC

Lobbying Income

$1.4M

Filings

Unique Clients

Active Period

2019–2026

Lobbying Income by Year

Registrant-reported income from clients on LDA filings

Year	Lobbying Income	Filings	Clients
2026	$60,000	3	2
2025	$120,000	6	2
2024	$120,000	4	1
2023	$272,000	16	5
2022	$424,000	21	5
2021	$280,000	17	4
2020	$55,000	12	4
2019	$40,000	3	1

Largest clients by registrant-reported income

Client	Reported Income	Filings	Period
NANODX	$605,000	27	2020–2026
AMICUS THERAPEUTICS, INC.	$240,000	18	2019–2023
PARATEK PHARMACEUTICALS	$216,000	8	2022–2023
APELLIS PHARMACUETICALS	$200,000	13	2020–2023
TAYSHA GENE THERAPIES	$110,000	13	2020–2023
STUDENTS FOR LIFE OF AMERICA	—	3	2025–2026

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	71
SENATE	71
Health & Human Services, Dept of (HHS)	3

Most frequently reported lobbying issues

Issue Code	Description	Reports
Medicare/Medicaid	Medicare/Medicaid	76
Health Issues	Health Issues	54
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	34
Defense	Defense	6
Budget/Appropriations	Budget/Appropriations	4
Food Industry (safety, labeling, etc.)	Food Industry (safety, labeling, etc.)	1

ACUITY STRATEGIC PARTNERS LLC — Lobbying Disclosure | Poliscope